(Update: The NIH provided a response to our comments on July 16, 2018) Below are comments sent by KEI, UACT and HealthGap, regarding a proposed exclusive license to Morphiex Biotherapeutics, an entity for which little is known. The license concerns… Continue Reading
I’m about to deliver this intervention at the WIPO SCCR 36 meeting, as a general statement on limitations and exceptions. We are given 2 minutes. KEI has three points 1. The 1971 Berne Annex, which deals with access for developing… Continue Reading
At the 71st World Health Assembly, KEI will deliver the following intervention regarding the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018. 11.7 Preparation for… Continue Reading
On Friday May 11, 2018, the Department of Health and Human Services (DHHS) held its annual listening session in advance of the upcoming Seventy-First World Health Assembly. Comments were limited to 2 minutes, with no time set aside for a… Continue Reading
On Friday May 11, 2018, the Department of Health and Human Services (DHHS) held its annual listening session in advance of the upcoming Seventy-First World Health Assembly. Comments were limited to 2 minutes, with no time set aside for a… Continue Reading
On Friday May 11, 2018, the Department of Health and Human Services (DHHS) held its annual listening session in advance of the upcoming World Health Assembly. Comments were limited to 2 minutes, with no time set aside for a question… Continue Reading
The following statement can be attributed to James Love, Director, on May 11, 2018. “The Trump Administration is proposing that the U.S. government advocate higher drug prices in foreign countries. We’ll have to see the details of how this effort… Continue Reading
In advance of the 71st World Health Assembly (21 May 2018 – 26 May 2018), the World Health Organization (WHO) published a document (A71/INF./2, 19 April 2018) entitled, Voluntary contributions by fund and by contributor, 2017. Total voluntary contributions to… Continue Reading
On 14 February 2018 and 16 February 2018, the World Trade Organization (WTO) conducted a Trade Policy Review (TPR) of Malaysia. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes… Continue Reading
KEI was invited to participate in the “WHO Global Dialogue on Partnerships for Sustainable Financing of Noncommunicable Disease (NCD) Prevention and Control,” which was held in Copenhagen, Denmark, April 9-11, 2018. A web page for the event is here. Overall,… Continue Reading